Autopsy report · NCT05438485
Natural History Study of Patients With Methylmalonic Acidemia and Propionic Acidemia
Cause of deathFunding or business
“The decision to terminate the study was based on business considerations by the Sponsor.”
Life of this trial
- Registered 10 months after it had already started.
- Ran for about 2 years 2 months before it stopped.
- 11 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Sponsor
- HemoShear Therapeutics
- Sponsor type
- Industry
- Conditions
- Methylmalonic Acidemia; Propionic Acidemia
- Interventions
- Registry
- Participants
- 11
- Sites
- 3
- Countries
- Canada, United Kingdom, United States
Trials that died the same way
- The REBALANCE Study - a Prospective, Multicenter, Randomized, Pivotal Study of the May Health System
“Business decision by sponsor to terminate the study” - Trial to Investigate the Safety and Efficacy of GWP42003-P Versus Placebo as Adjunctive Therapy in Participants With Schizophrenia Experiencing Inadequate Response to Ongoing Antipsychotic Treatment
“This study was terminated based on a business decision by the Sponsor.” - Study of Viziatek ISL™ Refractive Phakic Intra Sulcus Lens for Refraction Adjustment in Blind Volunteers
“Sponsor decision to terminate the study” - Developing Affective HeaLth to Improve Adherence to Health Behaviors in Diabetes (DAHLIA II)
“The Sponsor chose to terminate this study for commercial reasons.” - Study of RP-6306 With FOLFIRI in Advanced Solid Tumors
“Sponsor decided to terminate the study”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.